- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- monomer
- Ligands
- 2 x CA: CALCIUM ION(Non-covalent)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 1 residues within 4Å:- Chain A: N.265
No protein-ligand interaction detected (PLIP)NAG.4: 5 residues within 4Å:- Chain A: F.261, P.263, E.264, N.341, S.343
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.264, A:S.343
NAG.5: 2 residues within 4Å:- Chain A: D.1307, N.1310
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.1310
NAG.6: 3 residues within 4Å:- Chain A: T.1312, N.1313, S.1315
No protein-ligand interaction detected (PLIP)- 1 x DZR: ~{N}-[[1-[2-(~{tert}-butylamino)-2-oxidanylidene-ethyl]piperidin-4-yl]methyl]-3-chloranyl-5-fluoranyl-benzamide(Non-covalent)
- 8 x 3PE: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)(Non-functional Binders)
3PE.8: 7 residues within 4Å:- Chain A: F.388, Y.389, R.1648, N.1649, G.1651, M.1652, L.1655
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:Y.389
- Hydrogen bonds: A:R.1648, A:N.1649, A:N.1649
3PE.9: 6 residues within 4Å:- Chain A: N.358, G.360, W.363, A.1491, H.1494
- Ligands: 3PE.10
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.358
- Salt bridges: A:H.1494
3PE.10: 8 residues within 4Å:- Chain A: F.241, G.360, Y.361, W.363, I.364, S.823, I.830
- Ligands: 3PE.9
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.241, A:Y.361, A:W.363, A:I.364, A:I.364, A:I.830
3PE.11: 9 residues within 4Å:- Chain A: L.767, L.771, K.775, S.820, T.821, S.822, W.824, A.825, A.831
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.767, A:L.771, A:A.831
- Hydrogen bonds: A:T.821
- Salt bridges: A:K.775
3PE.12: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)3PE.13: 9 residues within 4Å:- Chain A: C.1282, V.1390, T.1662, L.1698, Q.1701, F.1702, V.1705
- Ligands: DZR.7, Y01.17
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:V.1390, A:F.1702, A:F.1702
3PE.14: 10 residues within 4Å:- Chain A: I.761, L.795, I.798, V.799, F.802, P.1373, W.1374, L.1376, L.1377, I.1380
13 PLIP interactions:13 interactions with chain A- Hydrophobic interactions: A:I.761, A:L.795, A:I.798, A:V.799, A:F.802, A:F.802, A:P.1373, A:W.1374, A:W.1374, A:W.1374, A:L.1376, A:L.1377, A:I.1380
3PE.15: 9 residues within 4Å:- Chain A: V.717, T.720, F.721, M.724, F.1288, L.1291, N.1372, M.1375, S.1381
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:V.717, A:T.720, A:F.721, A:F.1288, A:L.1291, A:L.1291
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.16: 7 residues within 4Å:- Chain A: I.647, Y.649, N.1333, L.1334, G.1335, L.1338
- Ligands: Y01.17
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:I.647, A:Y.649, A:N.1333, A:L.1334, A:L.1338
- Hydrogen bonds: A:Y.649
Y01.17: 13 residues within 4Å:- Chain A: F.1285, R.1326, N.1333, G.1335, Q.1336, L.1338, M.1339, F.1342, T.1686, P.1690, V.1694
- Ligands: 3PE.13, Y01.16
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:F.1285, A:F.1285, A:L.1338, A:F.1342, A:F.1342, A:P.1690, A:V.1694
- Hydrogen bonds: A:N.1333, A:Q.1336
- Salt bridges: A:R.1326
Y01.18: 12 residues within 4Å:- Chain A: I.243, F.244, V.247, L.251, E.295, N.296, H.386, S.387, Y.389, N.390, I.392, Y.393
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:I.243, A:F.244, A:F.244, A:V.247, A:V.247, A:L.251, A:Y.389, A:I.392
- Hydrogen bonds: A:N.296, A:H.386
- Salt bridges: A:H.386
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Y. et al., Cryo-EM structures of apo and antagonist-bound human Cav3.1. Nature (2019)
- Release Date
- 2019-12-18
- Peptides
- Voltage-dependent T-type calcium channel subunit alpha-1G,Voltage-dependent T-type calcium channel subunit alpha-1G: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- monomer
- Ligands
- 2 x CA: CALCIUM ION(Non-covalent)
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x DZR: ~{N}-[[1-[2-(~{tert}-butylamino)-2-oxidanylidene-ethyl]piperidin-4-yl]methyl]-3-chloranyl-5-fluoranyl-benzamide(Non-covalent)
- 8 x 3PE: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE(Non-covalent)(Non-functional Binders)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhao, Y. et al., Cryo-EM structures of apo and antagonist-bound human Cav3.1. Nature (2019)
- Release Date
- 2019-12-18
- Peptides
- Voltage-dependent T-type calcium channel subunit alpha-1G,Voltage-dependent T-type calcium channel subunit alpha-1G: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.